Numerous studies in the sports field have shown that doses ranging from a few hundred milligrams to 10 g daily, both with single and chronic administration, result in a general improvement in the athletes energy metabolism and an increase in performance
Tirzepatide is administered as a once-weekly subcutaneous injection, with a recommended starting dose of 2.5 mg once weekly for 4 weeks, then increasing by 2.5 mg every 4 weeks until the target dose (up to 15 mg) is reached
Avoiding fats, oils, nuts, and seeds
2-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced barrier dysfunction and dextran sodium sulfate-induced colitis by improving intestinal barrier function and modulating the intestinal microbiome
Larger vials take slightly longer to dissolve (1520 minutes is typical for a 10mg vial vs 510 minutes for 1mg), but the diffusion process is the same
At Swiss Medica, we combine stem cell therapy with ongoing therapeutic support and medical supervision